These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2296483)

  • 1. Immunizations to the deltoid region.
    Bergeson PS
    Pediatrics; 1990 Jan; 85(1):134-5. PubMed ID: 2296483
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of needle change and air bubble in syringe on minor adverse reactions associated with diphtheria-tetanus toxoids-pertussis-polio vaccination in infants.
    Ipp M; Goldbach M; Greenberg S; Gold R
    Pediatr Infect Dis J; 1990 Apr; 9(4):291-3. PubMed ID: 2336316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Benign intracranial hypertension caused by DTP and polio immunization].
    Castillo Salinas F; Solé Mir E; Ferrer Comalat A; Morales Sánchez M
    An Esp Pediatr; 1990 May; 32(5):466-7. PubMed ID: 2400165
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
    Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
    Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
    Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
    Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current process of immunizations: vaccination schedule].
    Adán Pérez M; del Pozo Machuca J; Adán Gil M; Sánchez López C
    An Esp Pediatr; 1991 Oct; 35 Suppl 45():31-5. PubMed ID: 1763869
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length.
    Ipp MM; Gold R; Goldbach M; Maresky DC; Saunders N; Greenberg S; Davy T
    Pediatrics; 1989 May; 83(5):679-82. PubMed ID: 2717284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric combined formulation DTaP-IPV/Hib vaccine.
    White C; Halperin SA; Scheifele DW
    Expert Rev Vaccines; 2009 Jul; 8(7):831-40. PubMed ID: 19538110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious.
    King GE; Hadler SC
    Pediatr Infect Dis J; 1994 May; 13(5):394-407. PubMed ID: 8072822
    [No Abstract]   [Full Text] [Related]  

  • 16. Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8-12-year-old children.
    Bernsen RM; de Jongste JC; Koes BW; Aardoom HA; van der Wouden JC
    Vaccine; 2006 Mar; 24(12):2035-42. PubMed ID: 16368169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus vaccine policy.
    Bader M
    Am J Dis Child; 1990 Apr; 144(4):453-4. PubMed ID: 2321608
    [No Abstract]   [Full Text] [Related]  

  • 19. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Booster vaccination at 1 year with a rabies vaccine associated with DTP-IPV in infants living in a rabies endemic country.
    Lang J; Rongrre N; Plotkin S; Hoa DQ; Gioi NV; Le TT
    J Trop Pediatr; 1999 Jun; 45(3):181-3. PubMed ID: 10401204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.